Study finds HIV breastfeeding risk highest in early months after birth

August 24, 1999

An infant's risk of becoming infected with the AIDS virus through breastfeeding is highest during the first few months of life, according to a new study conducted among HIV-infected mothers and their babies in the African nation of Malawi. A mother's inexperience with breastfeeding may increase HIV transmission risk.

A report of the study by researchers from the National Institutes of Health, the Johns Hopkins School of Hygiene and Public Health in Baltimore, MD, and the Malawi College of Medicine in Blantyre, Malawi, appears in the August 25 issue of the Journal of the American Medical Association.

"This is a very important area of research," comments Anthony S. Fauci, M.D., director of the National Institute of Allergy and Infectious Diseases (NIAID), which co-funded the study with the National Cancer Institute (NCI). "Little is known about the timing of HIV infection through breastfeeding or the associated risk factors. This finding and other ongoing studies will help HIV-infected women make informed decisions about infant feeding."

Breastfeeding is the recommended method of infant feeding in Malawi and other developing countries, where alternatives to breast milk are often scarce, unsafe or culturally unacceptable. In the United States, where safe alternatives to breast milk are plentiful, HIV-infected women are advised against breastfeeding their infants.

Lead author Paolo Miotti, M.D., of NIAID's Division of AIDS, senior author Robert J. Biggar, M.D., of NCI's Division of Cancer Epidemiology and Genetics, and their colleagues investigated the timing of, and risk factors for, HIV infection among breastfed infants of HIV-infected mothers. The researchers tested infants for HIV infection during visits to the postnatal care clinic of a large urban hospital in Malawi. Only babies who tested negative for HIV at their first visit, six weeks after birth, were included in the study. The researchers' objective was to examine breastfeeding-related HIV infections. Positive HIV tests during the first weeks of life can result from infection that occurred during pregnancy or childbirth as well as through breastfeeding.

Subsequent HIV tests conducted over the next two years revealed that 47 of the 672 infants in the study became HIV-infected from breastfeeding. Nearly half (21) of the infections occurred within five months after birth. Another 15 babies became infected between postnatal months 6 and 11, and seven more between months 12 and 17 of follow-up. Only four HIV infections occurred between months 18 and 23. No babies became infected with HIV after they stopped breastfeeding.

Statistical analyses showed that women who had fewer than four previous births were more likely to transmit HIV through breast milk than were women who had four or more. Similarly, younger mothers were more likely than older mothers to transmit HIV through breast milk.

Drs. Miotti, Biggar and their colleagues speculate that mothers who are relatively less experienced with breastfeeding are more likely to have subclinical mastitis, an inflammation of the mammary tissue, and thereby a higher HIV transmission rate. The researchers note that in another recent study conducted among a separate population of women in Malawi, they found that subclinical mastitis was associated with higher HIV levels in breast milk and higher HIV transmission to breastfeeding infants.

"HIV transmission was highest in the early months, but persisted for as long as infants continued breastfeeding," notes Dr. Miotti. "Early weaning has been proposed as one possible strategy to limit HIV transmission through breast milk," he adds. "Although discontinuing breastfeeding after six months would have prevented half of the HIV infections seen in our study, such an approach would increase the risk for illness and death from the respiratory and diarrheal diseases that antibodies and other factors in breast milk help protect against."

The researchers conclude that breastfeeding recommendations for HIV-infected women in developing countries must carefully balance the risk of HIV transmission with the well-known nutritional and health benefits of breastfeeding. "Recommendations may be most usefully made at the level of the individual mother, since communities in developing countries include women from varied socioeconomic strata who have different access to safe-milk alternatives."

NCI and NIAID are components of the National Institutes of Health (NIH). NCI is the principal federal agency working to prevent cancer and help patients live longer and healthier lives. NIAID conducts and supports research to prevent, diagnose and treat illnesses such as HIV disease and other sexually transmitted diseases, tuberculosis, malaria, asthma and allergies. NIH is an agency of the U.S. Department of Health and Human Services.
-end-
Reference:
PG Miotti, TET Taha, NI Kumwenda, et al. HIV transmission through breastfeeding: a study in Malawi. JAMA 282:744-49 (1999).

Press releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at http://www.niaid.nih.gov.

NIH/National Institute of Allergy and Infectious Diseases

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.